Skip to main content
    O

    OS Therapies Incorporated (OSTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.68
    -0.06 (-8.66%)

    Market Cap: $34.87M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    OS Therapies Incorporated (OSTX) Earnings: Report Dates and Results

    Updated Aug 14, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Jun 30, 2026, OS Therapies reported EPS of -$0.20, above the -$0.25 estimate. It beat the EPS estimate in 1 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    13%(1/8)
    Avg Surprise
    -67.62%
    Streak
    1 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.16
    Range-$0.20 - -$0.11
    6 analysts
    Revenue Consensus
    N/A
    RangeN/A
    6 analysts

    Next Report

    OSTX's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 8 quarters below that had an estimate, OSTX beat 1 and missed 7. The widest gap in the table came in the quarter ended Dec 31, 2025, when EPS landed 192.86% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Jun 30, 2026-$0.20-$0.25-$0.27 - -$0.19+20.00%BeatN/A30 up, 1 downAug 14, 2026
    Mar 31, 2026-$0.27-$0.19-$0.19 - -$0.19-42.11%MissN/A20 up, 0 downMay 18, 2026
    Dec 31, 2025-$0.41-$0.14-$0.22 - -$0.06-192.86%MissN/A41 up, 1 downMar 31, 2026
    Sep 30, 2025-$0.21-$0.12-$0.18 - -$0.07-75.00%MissN/A40 up, 2 downNov 14, 2025
    Jun 30, 2025-$0.19-$0.15-$0.16 - -$0.04-26.67%MissN/A30 up, 1 downAug 19, 2025
    Mar 31, 2025-$0.18-$0.11N/A-63.64%MissN/AN/AN/AMay 15, 2025
    Dec 31, 2024-$0.19-$0.14N/A-35.71%MissN/A20 up, 0 downMar 31, 2025
    Sep 30, 2024-$0.18-$0.08-$0.16 - -$0.08-125.00%MissN/A20 up, 0 downNov 15, 2024
    Jun 30, 2024-$0.61N/AN/AN/AN/AN/AN/AN/AAug 14, 2024
    Last 9 quarters

    Annual EPS

    Fiscal year endedEPSChange
    Sep 30, 2026-$0.47N/A
    Jun 30, 2026-$0.47N/A
    Dec 31, 2025-$0.99N/A
    Jun 30, 2025-$0.37N/A
    Dec 31, 2024-$0.98N/A

    Frequently Asked Questions About OSTX

    Did OSTX beat earnings estimates last quarter?

    Yes. OS Therapies reported EPS of -$0.20 for the quarter ended Jun 30, 2026, above the -$0.25 estimate, a 20.00% surprise.

    What EPS do analysts expect from OSTX next quarter?

    The consensus EPS estimate for OS Therapies for the quarter ending Dec 31, 2026 is -$0.16 from 6 analysts, with estimates from -$0.20 to -$0.11.

    How often does OSTX beat earnings estimates?

    OS Therapies beat the EPS estimate in 1 of the last 8 quarters, with an average surprise of -67.62%.